Tradestie Institutional Equity Comparison Engine

QNRX vs ILAG โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

QNRX Overall Edge

QNRX Captures Institutional Edge (2โ€“1 Pillars ยท 5โ€“3 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Quoin Pharmaceuticals, Ltd. American Depositary Shares (QNRX) driven by superior Valuation, Growth & Margin while ILAG counters with relative strength in Momentum & Technical. Fundamentally, QNRX trades at N/M Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus ILAG at N/M Forward P/E and -279.6% operating margin (+2.3% YoY). In options structure, QNRX sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against ILAG sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner QNRX
QNRX N/M vs ILAG N/M Fwd P/E
Growth & Margin Winner QNRX
Op Margin 0.0% vs -279.6% ยท YoY +0.0% vs +2.3%
Momentum & Technical Winner ILAG
1Y -82.0% vs +146.8% ยท 52W Pos 0% vs 18%
Options & Structure Winner Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
QNRX NASDAQ
Quoin Pharmaceuticals, Ltd. American Depositary Shares
Pharmaceutical Preparations
$3.28
-2.35% 1D
Market Cap $16.1M
1M Return -18.2%
1Y Return -81.96%
Forward P/E N/M
Unified AI Score
46.1 / 100 HOLD
Tech 38.0 Fund 47.0 Flow 50.0 Mom 64.0
ILAG NASDAQ
Intelligent Living Application Group Inc. Ordinary Shares
Partitions, Shelvg, Lockers, & Of Fice & Store Fixtures
$1.53
-16.85% 1D
Market Cap $3.3M
1M Return -37.04%
1Y Return +146.77%
Forward P/E N/M
Unified AI Score
49.6 / 100 HOLD
Tech 38.0 Fund 69.0 Flow 50.0 Mom 45.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: QNRX -81.96% ILAG +146.77% Spread: +295.48 pp (ILAG Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
QNRX TTM Op. Margin: 0.0% ILAG TTM Op. Margin: -279.6%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on QNRX vs ILAG. Trailing 12-month operating profitability (QNRX 0.0% vs ILAG -279.6%) and valuation multiples (QNRX N/M vs ILAG N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: QNRX (5) vs ILAG (3)
Institutional Metric QNRX ILAG Criterion Row Winner
Market Capitalization Scale $16.1M $3.3M Larger Scale QNRX
Trailing P/E Ratio Valuation 7.6x N/M Lower Multiple QNRX
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth +0.0% +2.3% Higher Growth ILAG
Operating Margin (TTM) Profitability 0.0% -279.6% Higher Margin QNRX
Net Profit Margin Profitability 0.0% 0.0% Higher Margin Tie
Return on Equity (ROE) Capital Efficiency -142.6% -215.3% Higher ROE QNRX
52-Week Range Position Momentum 0% ($3โ€“$24) 18% ($0โ€“$7) Stronger Trend ILAG
Beta / 30D Volatility Risk Regime 1.34ฮฒ ยท 74% Vol 0.81ฮฒ ยท 94% Vol Lower Realized Risk QNRX
Unified Institutional Score Composite Signal 46.1 / 100 (HOLD) 49.6 / 100 (HOLD) Higher Composite ILAG

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full QNRX vs ILAG Buy Guide
QNRX UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live QNRX Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
ILAG UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live ILAG Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither QNRX nor ILAG registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.